Viveve
Company

Last deal

$18.8M

Amount

Post-IPO Equity

Stage

06.12.2018

Date

11

all rounds

$172.6M

Total amount

General

About Company
Viveve develops non-surgical treatment for women's sexual health.

Industry

Sector :

Subsector :

Also Known As

Viveve Medical

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's Viveve System is a radiofrequency device that restores collagen fibers damaged during vaginal childbirth, treating vaginal looseness and loss of physical sensation. The system is also used for vaginal rejuvenation, stress urinary incontinence, and electrocoagulation and hemostasis in general surgical procedures. Viveve has a global business presence, with operations in the US, Asia Pacific, Canada, Europe, Middle East, and Latin America.
Contacts

Social url